Exact Sciences (EXAS) –
-
Form ARS EXACT SCIENCES CORP For: Dec 31
-
Form DEFA14A EXACT SCIENCES CORP
-
Form DEF 14A EXACT SCIENCES CORP For: Jun 13
-
Exact Sciences (EXAS) PT Raised to $84 at Baird
-
Form 8-K EXACT SCIENCES CORP For: Apr 17
-
Form 8-K EXACT SCIENCES CORP For: Apr 15
-
Exact Sciences (EXAS) Appoints Aaron Bloomer as CFO
-
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
-
Exact Sciences (EXAS) Announces Debt Exchange Transaction, Private Convertible Notes Placement
-
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
-
Exact Sciences (EXAS) to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR
-
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
-
Exact Sciences Schedules First Quarter 2024 Earnings Call
-
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
-
Form 4 EXACT SCIENCES CORP For: Apr 01 Filed by: Condella Sarah
-
Form 4 EXACT SCIENCES CORP For: Apr 02 Filed by: Baranick Brian
-
Citi Upgrades Sotera Health (SHC) to Buy
-
Citi Downgrades Bio-Rad Labs (BIO) to Neutral
-
Citi Opens 90-Day Upside Catalyst Watch on Exact Sciences (EXAS)
-
Form 144 EXACT SCIENCES CORP Filed by: Baranick Brian
-
Form 4 EXACT SCIENCES CORP For: Mar 28 Filed by: Condella Sarah
-
Form 144 EXACT SCIENCES CORP Filed by: Condella Sarah
-
Form 144 EXACT SCIENCES CORP Filed by: Condella Sarah
-
Exact Sciences (EXAS) Advances Development of Non-Endoscopic Oncoguard Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
-
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
-
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
-
Increasing unusual put option volume: JBL SOUN GERN EH DRI MDGL EXAS
-
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
-
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
-
Form 4 EXACT SCIENCES CORP For: Feb 29 Filed by: ORVILLE JACOB A
-
Form 4 EXACT SCIENCES CORP For: Mar 01 Filed by: LEVANGIE DANIEL J
-
Form 4 EXACT SCIENCES CORP For: Feb 29 Filed by: Herriott James
-
Form 4 EXACT SCIENCES CORP For: Mar 01 Filed by: Doyle James Edward
-
Form 4 EXACT SCIENCES CORP For: Feb 29 Filed by: Elliott Jeffrey Thomas
-
Form 4 EXACT SCIENCES CORP For: Feb 29 Filed by: Cunningham Everett
-
Form 4 EXACT SCIENCES CORP For: Feb 29 Filed by: Condella Sarah
-
Form 4 EXACT SCIENCES CORP For: Feb 29 Filed by: Conroy Kevin T
-
Form 4 EXACT SCIENCES CORP For: Feb 29 Filed by: Baranick Brian
-
Form 144 EXACT SCIENCES CORP Filed by: Cunningham Everett
-
Form 144 EXACT SCIENCES CORP Filed by: Herriott James
-
Form 144 EXACT SCIENCES CORP Filed by: Elliott Jeffrey Thomas
-
Form 144 EXACT SCIENCES CORP Filed by: Condella Sarah
-
Form 144 EXACT SCIENCES CORP Filed by: ORVILLE JACOB A
-
Form 144 EXACT SCIENCES CORP Filed by: Baranick Brian
-
Form 144 EXACT SCIENCES CORP Filed by: Conroy Kevin T
-
Form 144 EXACT SCIENCES CORP Filed by: Doyle James Edward
-
Form 144 EXACT SCIENCES CORP Filed by: LEVANGIE DANIEL J
-
Form 4 EXACT SCIENCES CORP For: Feb 26 Filed by: ORVILLE JACOB A
-
Form 4 EXACT SCIENCES CORP For: Feb 26 Filed by: Herriott James
-
Form 4 EXACT SCIENCES CORP For: Feb 26 Filed by: Cunningham Everett
Back to EXAS Stock Lookup